Danaher (NYSE:DHR) issued an update on its FY19 earnings guidance on Thursday morning. The company provided earnings per share guidance of $4.75-4.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.85. Danaher also updated its FY 2019 guidance to $4.75-4.80 EPS.
Shares of DHR stock opened at $141.61 on Friday. The stock has a fifty day simple moving average of $140.27. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.74 and a current ratio of 2.18. The company has a market capitalization of $101.38 billion, a price-to-earnings ratio of 31.33, a PEG ratio of 2.56 and a beta of 0.96. Danaher has a 12 month low of $94.59 and a 12 month high of $145.50.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, July 18th. The conglomerate reported $1.19 EPS for the quarter, topping the Zacks’ consensus estimate of $1.15 by $0.04. The business had revenue of $5.16 billion for the quarter, compared to analyst estimates of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.73%. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.15 earnings per share. As a group, equities analysts predict that Danaher will post 4.77 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date is Thursday, June 27th. Danaher’s dividend payout ratio is presently 15.04%.
DHR has been the topic of a number of research reports. Zacks Investment Research lowered shares of GALP ENERGIA SG/ADR from a hold rating to a sell rating in a research report on Monday, May 6th. Janney Montgomery Scott boosted their price objective on shares of Danaher from $136.00 to $174.00 and gave the stock a buy rating in a research report on Wednesday, April 17th. Robert W. Baird upped their price target on shares of Danaher from $131.00 to $148.00 and gave the stock an outperform rating in a research report on Friday. Needham & Company LLC reaffirmed a buy rating and set a $155.00 price target (up from $142.00) on shares of Danaher in a research report on Friday. Finally, Wolfe Research began coverage on shares of Waters in a research report on Thursday, May 30th. They set an underperform rating on the stock. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average price target of $139.08.
In other Danaher news, Director Alan G. Spoon sold 1,913 shares of the company’s stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total value of $247,771.76. Following the transaction, the director now directly owns 86,863 shares in the company, valued at $11,250,495.76. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP William King sold 12,950 shares of the company’s stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $129.92, for a total transaction of $1,682,464.00. Following the completion of the transaction, the senior vice president now owns 29,070 shares in the company, valued at $3,776,774.40. The disclosure for this sale can be found here. Insiders have sold 453,448 shares of company stock worth $59,724,640 over the last ninety days. Insiders own 11.40% of the company’s stock.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: How is a buy-side analyst different from a sell-side analyst?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.